← 1 October 2026Sourcery with Molly O'Shea
Annie Lamont: $14B Managed, 70+ Exits, 15 IPOs, 7x Midas Investor
Annie Lamont argues AI has reached the point of real impact in drug discovery and healthcare, that founder quality and defensibility matter more than hype, and that most inflated AI valuations won't hold.
Watch on YouTube ↗No quote from this episode passed Charlie's judge.
Do more with Charlie
Analyze any YouTube videoPaste a link — get its key points and best quotes in minutes. 10 videos a day.Paste a YouTube link →Your own podcast feedAdd up to 10 YouTube channels you follow. Charlie reads their new episodes for you.Add your channels →
Free — sign in with your email, no password.